An elderly person is vaccinated with the Pfizer BioNTech Covid-19 vaccine at a nursing home in Norway. Photo: EPA-EFE
An elderly person is vaccinated with the Pfizer BioNTech Covid-19 vaccine at a nursing home in Norway. Photo: EPA-EFE
Nathan Bartlett
Opinion

Opinion

Nathan Bartlett

Pfizer coronavirus vaccine and frail people: too early to make firm conclusions

  • Reports of about 30 deaths among elderly people who took the Pfizer-BioNTech Covid-19 vaccine in Norway have raised safety concerns
  • But while it may not be the best choice for frail people, the vaccine should ideally be considered on a case-by-case basis

An elderly person is vaccinated with the Pfizer BioNTech Covid-19 vaccine at a nursing home in Norway. Photo: EPA-EFE
An elderly person is vaccinated with the Pfizer BioNTech Covid-19 vaccine at a nursing home in Norway. Photo: EPA-EFE
READ FULL ARTICLE